Solesence, Inc. Files 8-K with Financial Updates

Ticker: SLSN · Form: 8-K · Filed: Nov 13, 2025 · CIK: 883107

Sentiment: neutral

Topics: financial-results, operations, company-update

TL;DR

Solesence (SOL) dropped an 8-K on 11/11/25 with financial results. Check it out.

AI Summary

On November 11, 2025, Solesence, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, providing an update on the company's performance. Solesence, Inc., formerly Nanophase Technologies Corp, is based in Romeoville, Illinois.

Why It Matters

This 8-K filing provides investors with crucial, up-to-date financial information and operational details for Solesence, Inc., enabling informed investment decisions.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial results and does not indicate any unusual or high-risk events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Solesence, Inc.?

The primary purpose is to report on the Results of Operations and Financial Condition, along with Financial Statements and Exhibits, as of November 11, 2025.

When was the earliest event reported in this filing?

The earliest event reported was on November 11, 2025.

What was Solesence, Inc. formerly known as?

Solesence, Inc. was formerly known as Nanophase Technologies Corp and Nanophase Technologies CORPORATION.

Where are Solesence, Inc.'s principal executive offices located?

Solesence, Inc.'s principal executive offices are located at 1319 Marquette Drive, Romeoville, Illinois, 60446.

What is the SIC code for Solesence, Inc.?

The Standard Industrial Classification (SIC) code for Solesence, Inc. is 2844, which corresponds to PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS.

Filing Stats: 415 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2025-11-12 19:30:28

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On November 11, 2025, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. 99.1 Press Release dated November 11, 2025 99.2 Solsence Third Quarter 2025 Conference Call Script 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SOLESENCE, INC. Date: November 12, 2025 By: /s/ Laura Riffner Laura Riffner Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing